Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
59.35 M
Public Float
51.87 M
BioDelivery Sciences International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.6
Market Cap
$413.56 M
Shares Outstanding
89.43 M
Public Float
65.12 M

Profile

Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Financials

View All
Created with Highcharts 5.0.14BioDelivery Sciences International Inc.Net Income. Fiscal year is January-December. All values USD Thousands.57 39357 39354 21854 21837 67237 67267 13867 1385 2855 28533 86733 867201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14BioDelivery Sciences International Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.11 35511 35538 94438 94448 23148 23115 54615 54661 98561 98555 64055 640201320142015201620172018020k40k60k80k

Herm Cukier
Chief Executive Officer & Director
Kevin Kotler
Director